The Mycelium Report
Your one trusted source for everything psilocybin — curated weekly from medical journals, research papers, podcasts, YouTube, and news outlets around the world. We do the searching so you don't have to, bringing the latest science, stories, and conversations directly to our community.
Never Miss What Matters
One weekly email. The best psilocybin research, podcasts, and news from trusted sources around the world — no searching required.
Psilocybin for Veterans: Bill Proposes $30M in Federal Funding
The Innovative Therapies Centers of Excellence Act of 2025, a bipartisan Senate bill, would allocate $30 million per year to fund at least five VA medical facilities offering…
Functional Mushrooms and the Hype Cycle: What the Science Actually Says
In a December 2025 podcast conversation, UK-based fungi educator Oli Genn-Bash argued that the functional mushroom market is accelerating past its evidence base. Drawing on lion’s mane as…
Psilocybin and Aging: What a New Review Found
A 2024 review paper by Mark Haden and colleagues, published in a peer-reviewed outlet and summarized by Drug Science, argues that psilocybin and other psychedelics may affect multiple…
Psilocybin Approval: FDA Hears Debate on Access and Safety
On September 14, 2026, the FDA held a public hearing to gather input on how psychedelic medicines should be used after approval. Speakers disagreed sharply on provider qualifications,…
Psilocybin and Anxiety: A Hippocampal Reset Theory
A theoretical paper published in Psychopharmacology in 2026 proposes that anxiety disorders may involve a kind of stuck pattern in the hippocampus, a brain structure central to memory…
Psilocybin for Traumatic Brain Injury: What a Narrative Review Found
A narrative review indexed on NIH platforms examined the possible mechanisms by which psilocybin could support recovery from traumatic brain injury, focusing on neuroplasticity pathways. The review is…
Psilocybin for Depression in Health Care Workers: Early Signal
A University of Utah report, published in late October 2025, describes preliminary research into psilocybin as a possible intervention for depression among health care workers. Full methodology and…
Psilocybin for Migraine: What Early Studies Found
In a small pilot trial of 10 adults with migraine, participants reported fewer attacks and less severe pain during the two weeks following low-dose oral psilocybin. A separate…
You've Come This Far. Stay Informed.
Join our free weekly newsletter and get the best psilocybin research, medical journals, podcasts, and news — hand-curated from trusted sources around the world and delivered straight to your inbox.